CSIMarket Company Name, Ticker, Competitors, else..
 
Inspiremd Inc   (NASDAQ: NSPR)
 
Price: $0.8532 $0.01 1.571%
Day's High: $0.8985999822616577 Week Perf: -4.13 %
Day's Low: $ 0.82 30 Day Perf: 18.5 %
Volume (M): 30,326 52 Wk High: $ 2.57
Volume (M$): $ 0 52 Wk Avg: $1.52
Open: $0.83 52 Wk Low: $0.63



 Market Capitalization (Millions $) 72
 Shares Outstanding (Millions) 85
 Employees 127
 Revenues (TTM) (Millions $) 11
 Net Income (TTM) (Millions $) -52
 Cash Flow (TTM) (Millions $) 0
 Capital Exp. (TTM) (Millions $) 1

Business Description


Inspiremd Inc is a medical technology company that specializes in developing and commercializing neurovascular devices. Their flagship product is the CGuard™️ Embolic Prevention System, which is used to prevent strokes caused by the blockage of blood vessels in the brain. This innovative system is designed to capture and remove potential emboli during various endovascular procedures. Inspiremd Inc aims to provide effective and minimally invasive solutions for improving patient outcomes in the field of neurovascular medicine.


   Company Address: 6303 Waterford District Drive Miami 33126 FL
   Company Phone Number: 776-6804   Stock Exchange / Ticker: NASDAQ NSPR


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
ATRC        6.14% 
EW   -0.34%    
IART   -1.01%    
MDT        3.22% 
SYK   -8.33%    
TMDX        1.75% 
• View Complete Report
   



Shares

Navigating Choppy Waters: InspireMD’s Strategic Maneuvers and Market Positioning

Published Tue, Feb 25 2025 1:01 PM UTC

As InspireMD, Inc. (Nasdaq: NSPR) maneuvers through a dynamic healthcare landscape, the developer of the CGuard Prime carotid stent system continues to make news with strategic decisions and partnerships that could shape its future and fortify its market position. The latest announcement of inducement grants to new non-executive employees highlights a critical move aimed at ...
Shares

New Inducement Grants Could Propel InspireMD Towards Greater Innovations

Published Tue, Feb 4 2025 12:00 PM UTC

In a strategic maneuver to bolster its talent pool, InspireMD, Inc. (Nasdaq: NSPR), a pioneering medical device company focused on stroke prevention, has announced inducement grants under the Nasdaq Listing Rule 5635(c)(4). This development is poised to potentially influence the company s stock performance and could mark a significant milestone in its ongoing quest for innov...
Partnership

InspireMD and NAMSA Join Forces to Pioneer Pivotal Clinical Trial for Advanced Carotid Stenting Solutions

Published Thu, Feb 13 2025 1:16 PM UTC

In an exciting development for the medical technology landscape, InspireMD, Inc. (NASDAQ: NSPR), a trailblazer in carotid stenting solutions, has announced a strategic partnership with NAMSA, a renowned global MedTech Contract Research Organization (CRO). This collaboration is set to usher in the CGUARDIANS II pivotal clinical trial for the CGuard Prime 80 cm Carotid Stent S...
Shares

InspireMDs Inducement Grants Signal Ambitious Growth Strategy in Stroke Prevention Innovation,

Published Tue, Jan 21 2025 12:00 PM UTC

InspireMD Broadens Talent Pool with Strategic Inducement Grants Amid Growth in Carotid Stent DevelopmentIn a notable move highlighting its commitment to securing top talent as it continues to innovate within the medical technology space, InspireMD, Inc. (Nasdaq: NSPR), a leading developer of advanced vascular devices, recently approved substantial inducement grants to new no...
Shares

InspireMD Fuels Growth with Strategic Inducement Grants to Boost Workforce Innovation,

Published Fri, Nov 8 2024 10:30 PM UTC

InspireMD s Strategic Inducement Grants: A Step Towards Growth and StabilityIn a recent announcement that highlights its ongoing commitment to attracting top talent, InspireMD, Inc. (Nasdaq: NSPR) has provided details on the inducement grants approved by its Compensation Committee. This decision is emblematic of the company’s broader strategy to safeguard its innovative p...



Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) -
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) 6.88
Price to Sales (Expected) -
Price to Book 2.29
PEG (TTM) -

Financial Strength Current
Quick Ratio 3.15
Working Capital Ratio 3.8
Leverage Ratio (MRQ) 0.42
Total Debt to Equity -
Interest Coverage (TTM) -
Debt Coverage (TTM) -

Per Share Current
Earnings (TTM) -0.61 $
Revenues (TTM) 0.12 $
Cash Flow (TTM) -
Cash 0.36 $
Book Value 0.37 $
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) 82,693
Net Income per Employee (TTM) -413,244
Receivable Turnover Ratio (TTM) 5.05
Inventory Turnover Ratio (TTM) 2.78
Asset Turnover Ratio (TTM) 0.17

Profitability Ratios Current
Gross Margin (MRQ) -60.76 %
Operating Margin (MRQ) -815.64 %
Net Margin (MRQ) -808.81 %
Net Cash Flow Margin (MRQ) 0 %
Effective Tax Rate (TTM) -

Management Effectiveness Current
Return On Assets (TTM) -
Return On Investment (TTM) -
Return On Equity (TTM) -
Dividend Yield -
Pay out Ratio (TTM) -



Inspiremd Inc's Segments
Other Countries    127.27 % of total Revenue
Customer B    19.59 % of total Revenue





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.